Transocean LTD (NYSE:RIG) was downgraded by analysts at Vetr from a “buy” rating to a “hold” rating. They now have a $16.75 price target on the stock. On Thursday shares of Transocean Ltd. (NYSE:RIG) closed at $14.27. Company’s sales growth for last 5 years was -4.30%.
Bank of America Corporation (NYSE:BAC) announced it will report its first-quarter 2015 financial results on Wednesday, April 15. The results are scheduled to be released at 7 a.m. ET, followed by an investor presentation at 8:30 a.m. ET. Bank of America Corporation (NYSE:BAC) in last trading activity fell -0.12% to close at $16.09. Company weekly performance is 0.56% while its quarterly performance stands at -8.11%. Bank of America Corporation (NYSE:BAC) is -11.34% away from its 52 week high.
On March 4, OmniVision Technologies, Inc. (NASDAQ:OVTI) announced the OV16880, a new 16-megapixel image sensor built on OmniVision’s PureCel-S™ stacked die technology. The 1/3-inch OV16880 introduces a new 1-micron pixel technology from OmniVision that enables ultra-high resolution image and video capture, as well as advanced features such as phase detection autofocus (PDAF). On last trading day OmniVision Technologies, Inc. (NASDAQ:OVTI) advanced 0.68% to close at $26.61. Its volatility for the week is 1.60% while volatility for the month is 1.87%. OVTI’s sales growth for past 5 years was 23.40% and its EPS growth for past 5 years was 33.90%. OmniVision Technologies, Inc. (NASDAQ:OVTI) monthly performance is -1.77%.
TransEnterix, Inc. (NYSEMKT:TRXC)’s President and Chief Executive Officer Todd M. Pope, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, presented at the Barclays Global Healthcare Conference at the Lowes Hotel in Miami, Florida. The presentation is scheduled to take place at 1:35 pm Eastern Time on Thursday, March 12, 2015. TransEnterix, Inc. (NYSEMKT:TRXC) has 0.10% insider ownership while its institutional ownership stands at 64.60%. In last trading activity company’s stock closed at $2.60.
On March 4, Becton, Dickinson and Company (NYSE:BDX) said that it has acquired CRISI Medical Systems, a technology company that improves IV injectable medications. The acquisition assists BD, a leading technology company that innovates for the medical industry around the world, with its goal of remedying preventable errors in medications and deliveries. On last trading day Becton, Dickinson and Company (NYSE:BDX) advanced 1.45% to close at $143.04. Its volatility for the week is 1.56% while volatility for the month is 1.33%. BDX’s sales growth for past 5 years was 3.90% and its EPS growth for past 5 years was 4.80%. Becton, Dickinson and Company (NYSE:BDX) monthly performance is 1.27%.